At what induration size is a Purified Protein Derivative (PPD) test considered positive in an individual with close contact to a patient with active Tuberculosis (TB)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

PPD Interpretation in Close Contacts of Active TB Patients

For individuals with close contact to a patient with active tuberculosis, a PPD induration of ≥5 mm is considered positive. 1, 2

Risk-Stratified Interpretation of PPD Results

The interpretation of tuberculin skin test (TST) results is risk-stratified, with different cut-off values based on the individual's risk factors:

5 mm or greater (considered positive in):

  • Recent close contacts of TB cases
  • HIV-infected persons
  • Persons with fibrotic changes on chest radiograph consistent with prior TB
  • Organ transplant recipients and other immunosuppressed patients
  • Persons receiving TNF-α inhibitors 1, 3

10 mm or greater (considered positive in):

  • Recent immigrants from high-prevalence countries
  • Injection drug users
  • Residents and employees of high-risk congregate settings
  • Mycobacteriology laboratory personnel
  • Persons with clinical conditions that increase TB risk (diabetes, chronic renal failure, leukemias, etc.)
  • Children younger than 4 years of age
  • Infants, children, and adolescents exposed to adults in high-risk categories 1, 3

15 mm or greater (considered positive in):

  • Persons with no known risk factors for TB 1, 3

Clinical Implications for Close Contacts

Close contacts of individuals with active TB represent a high-priority group for TB screening and preventive therapy due to:

  • Higher likelihood of recent infection with M. tuberculosis
  • Increased risk of progression to active TB disease
  • Public health importance of breaking the chain of transmission 1

The lower threshold of 5 mm for close contacts ensures higher sensitivity for detecting latent TB infection in this high-risk population. This is particularly important since the risk of developing active TB is highest within the first two years following infection 1.

Management Considerations

When a close contact has a positive PPD result (≥5 mm):

  • Rule out active TB disease with symptom assessment and chest radiography
  • If active TB is excluded, initiate treatment for latent TB infection
  • The recommended regimen for latent TB infection is isoniazid for 9 months, although alternative regimens may be considered 1, 3

Common Pitfalls

  1. Misinterpreting BCG vaccination effects: Prior BCG vaccination can cause false-positive TST results, but this effect diminishes with time. In close contacts of active TB cases, a positive TST should be considered indicative of TB infection regardless of BCG history 1.

  2. Failing to recognize anergy: Immunosuppressed individuals may have false-negative TST results due to anergy. Consider anergy testing in HIV-infected persons 1.

  3. Delayed reading: TST should be read at 48-72 hours after administration for accurate results 1.

  4. Improper measurement technique: Only the transverse diameter of induration (not erythema) should be measured 1, 3.

The 5 mm threshold for close contacts of active TB cases reflects the higher pre-test probability of infection and the critical importance of early identification and treatment to prevent progression to active disease and further transmission.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tuberculosis Diagnosis and Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.